Dr. Eddie Méndez was a physician-scientist and cherished colleague at Fred Hutch who died of cancer in 2018 at age 45. An expert in head and neck cancers, Méndez was known for being passionate about ...

At Fred Hutch, we believe that quality of life is essential to building a rewarding career — and achieving our shared mission of advancing breakthroughs and saving lives. It starts with a supportive ...

The Prevention Center shared resource (PCSR) was founded with the goal of facilitating transdisciplinary, collaborative research focused on the prevention and mitigation of disease. Since 2004, over ...

Save the Date: the Sloan Precision Oncology Institute is hosting a Theranostics Symposium on February 28, 2025. This symposium will feature a panel of local and national leaders in the field who will ...

Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as ...

Fred Hutch Cancer Center Senior Vice President and Director of the Clinical Research Division Sara Hurvitz, MD, recently received the inaugural Smith Family Endowed Chair in Women’s Health. The new ...

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...

Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...

The turn of the calendar year marks a natural time to check in, evaluate goals, measure success and reset for the coming year and former patients of Fred Hutch Cancer Center – Proton Therapy are no ...

As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...

Colorectal cancer can be treated using immunotherapy approaches that use the immune cells to target cancer cells and induce the killing of those cancer cells. Some colorectal cancer types have been ...

Merkel cell carcinoma, or MCC, is so rare that newly diagnosed patients are often the first case their oncologist has ever treated. For many patients, understanding this aggressive skin cancer’s ...